PCP-2T

PCP-2T

A dual-agonist peptide targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. This first-in-class combination amplifies satiety signals, improves insulin sensitivity, and enhances glucose control beyond single-receptor agonists. Clinically proven for significant weight loss and blood sugar management. Key Benefits: – Dual Mechanism – Activates both GIP and GLP-1 pathways synergistically – Powerful Appetite Control – Significantly reduces hunger and food intake – Glucose Regulation – Improves insulin secretion and sensitivity – Substantial Weight Loss – Clinical trials show superior weight reduction – Cardiovascular Benefits – Researched for heart health improvements – Once-Weekly Dosing – Long-acting formulation for convenience Researched for weight management, type 2 diabetes, and metabolic health.